PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
This Quarter Return
-2.48%
1 Year Return
+3.35%
3 Year Return
+116.54%
5 Year Return
–
10 Year Return
–
AUM
$75.3M
AUM Growth
+$75.3M
(-25%)
Cap. Flow
-$13.9M
Cap. Flow
% of AUM
-18.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
UroGen Pharma
URGN
|
$13.2M |
| 2 |
IMDZ
Immune Design Corp.
IMDZ
|
$690K |
Sector Composition
| 1 | Healthcare | 75.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UroGen Pharma
URGN
$900M
| $40.8M | 54.17% |
1,096,024
-353,721
| -24% | -$13.2M |
|
2
Mersana Therapeutics
MRSN
$36.5M
| $15.7M | 20.86% |
955,709
| – | – |
|
|
AGRX
3
DELISTED
Agile Therapeutics, Inc
AGRX
| $13.6M | 18.09% |
5,062,363
| – | – |
|
|
IMDZ
4
DELISTED
Immune Design Corp.
IMDZ
| $4.82M | 6.4% |
1,236,394
-176,886
| -13% | -$690K |
|
|
EGRX
5
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $362K | 0.48% |
6,777
| – | – |
|